Topics

EU Commission grants orphan drug tag to BioLineRx's motixafortide

05:09 EST 15 Jan 2020 | SmartBrief

The European Commission granted BioLineRx's motixafortide, or BL-8040, orphan drug status as a treatment for pancreatic cance -More

Original Article: EU Commission grants orphan drug tag to BioLineRx's motixafortide

NEXT ARTICLE

More From BioPortfolio on "EU Commission grants orphan drug tag to BioLineRx's motixafortide"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...